BRNS Technical Analysis & Stock Price Forecast

Technical Sentiment

Overall Consensus

Sell

Buy

Technical Analysis Consensus

Sell

Buy

Moving Average Consensus

Sell

Buy

Barinthus Biotherapeutics PLC (BRNS) Moving Averages Convergence Divergence (MACD) indicator is -0.00557, suggesting BRNS is Sell.

Barinthus Biotherapeutics PLC (BRNS) 20-Day simple moving average is 0.57, while Barinthus Biotherapeutics PLC (BRNS) share price is $0.59, making it Buy.

Barinthus Biotherapeutics PLC (BRNS) 60-Day simple moving average is 0.623, while Barinthus Biotherapeutics PLC (BRNS) share price is $0.59, making it Sell.

Technical Analysis for BRNS

Technical Sentiment Analysis for Barinthus Biotherapeutics PLC (BRNS) As of 2026-04-20, Barinthus Biotherapeutics PLC (BRNS) is exhibiting a Sell technical sentiment. Our proprietary analysis, which aggregates 12 technical signals, shows that 5 indicators are flashing buy, while 7 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for BRNS stands at 50.46, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at -0.00557, providing a Sell signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 55.602 and the Commodity Channel Index (CCI) at 94.248 further confirm a 0.0214 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, BRNS is trading below its 60-day moving average of $0.623 and below its 200-day long-term moving average of $0.949. Key price levels to watch include the immediate resistance at $0.631 and strong support at $0.531. A break above $0.631 could signal a bull continuation, while falling below $0.531 may test the next Fibonacci floor at $0.485.

Barinthus Biotherapeutics PLC (BRNS) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	0.431	0.485	0.531	0.585	0.631	0.685	0.731
Fibonacci	0.485	0.524	0.547	0.585	0.624	0.647	0.685

Barinthus Biotherapeutics PLC (BRNS) Technical Indicators

2026-04-20

Name	Value
RSI_14	50.46
STOCHk_14_3_3	55.602
STOCHd_14_3_3	60.183
CCI_20	94.248
AO_5_34	0.00625
MOM_10	0.0214
MACD_12_26_9	-0.00557

Barinthus Biotherapeutics PLC (BRNS) Relative Strength Index (RSI) is 50.46, creating a Neutral signal.

Barinthus Biotherapeutics PLC (BRNS) Stochastic Oscillator is 55.602, creating a Neutral signal.

Barinthus Biotherapeutics PLC (BRNS) Stochastic RSI is 60.183, creating a Neutral signal.

Barinthus Biotherapeutics PLC (BRNS) Commodity Channel Index (CCI) is 94.248, creating a Neutral signal.

Barinthus Biotherapeutics PLC (BRNS) Awesome Oscillator is 0.00625, creating a Buy signal.

Barinthus Biotherapeutics PLC (BRNS) Momentum is 0.0214, creating a Buy signal.

Barinthus Biotherapeutics PLC (BRNS) MACD is -0.00557, creating a Sell signal.

Barinthus Biotherapeutics PLC (BRNS) Moving Average

2026-04-20

Period	Simple	Signal
MA_5	0.593	Sell
MA_10	0.576	Buy
MA_20	0.57	Buy
MA_60	0.623	Sell
MA_200	0.949	Sell
MA_250	0.943	Sell

Barinthus Biotherapeutics PLC (BRNS) 5-Day simple moving average is 0.593, while Barinthus Biotherapeutics PLC (BRNS) share price is $0.59, making it a Sell.

Barinthus Biotherapeutics PLC (BRNS) 10-Day simple moving average is 0.576, while Barinthus Biotherapeutics PLC (BRNS) share price is $0.59, making it a Buy.

Barinthus Biotherapeutics PLC (BRNS) 20-Day simple moving average is 0.57, while Barinthus Biotherapeutics PLC (BRNS) share price is $0.59, making it a Buy.

Barinthus Biotherapeutics PLC (BRNS) 60-Day simple moving average is 0.623, while Barinthus Biotherapeutics PLC (BRNS) share price is $0.59, making it a Sell.

Barinthus Biotherapeutics PLC (BRNS) 200-Day simple moving average is 0.949, while Barinthus Biotherapeutics PLC (BRNS) share price is $0.59, making it a Sell.

Barinthus Biotherapeutics PLC (BRNS) 250-Day simple moving average is 0.943, while Barinthus Biotherapeutics PLC (BRNS) share price is $0.59, making it a Sell.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for BRNS?

The overall technical consensus for Barinthus Biotherapeutics PLC (BRNS) is currently Sell. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 3 buy signals and 3 sell signals.

What are the key support and resistance levels for Barinthus Biotherapeutics PLC (BRNS) today?

Based on pivot point calculations, Barinthus Biotherapeutics PLC (BRNS) has an immediate support level at 0.531 and a major resistance level at 0.631. Traders also monitor the pivot point at 0.585 to determine the intraday trend direction.

Is Barinthus Biotherapeutics PLC (BRNS) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for Barinthus Biotherapeutics PLC (BRNS) is currently 50.46. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for Barinthus Biotherapeutics PLC (BRNS)?

Barinthus Biotherapeutics PLC (BRNS) Moving Averages Convergence Divergence (MACD) indicator is -0.00557, suggesting BRNS is Sell. This indicator helps identify potential trend reversals or momentum shifts for Barinthus Biotherapeutics PLC.

How is Barinthus Biotherapeutics PLC (BRNS) performing relative to its 200-day moving average?

Barinthus Biotherapeutics PLC (BRNS) is currently trading at $0.59, which is below its 200-day simple moving average of 0.949. Trading below the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.